Lv, F., Si, W., Xu, X., He, X., Wang, Y., Li, Y., & Li, F. (2024). RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells. Elsevier.
Lua i Stíl Chicago (17ú heag.)Lv, Fengxu, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, agus Feifei Li. RUNX2 Prompts Triple Negative Breast Cancer Drug Resistance Through TGF-β Pathway Regulating Breast Cancer Stem Cells. Elsevier, 2024.
Lua MLA (9ú heag.)Lv, Fengxu, et al. RUNX2 Prompts Triple Negative Breast Cancer Drug Resistance Through TGF-β Pathway Regulating Breast Cancer Stem Cells. Elsevier, 2024.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.